Jim Cramer: Will Allergan Go Shopping?
Allergan CEO Brent Saunders has plenty of deals to choose from now that the government has killed its tax inversion deal with Pfizer, said Jim Cramer.
Allergan (AGN) - Get Report CEO Brent Saunders has plenty of deals to choose from now that the government has officially killed its tax inversion deal with Pfizer (PFE) - Get Report , said TheStreet's Jim Cramer. He said the first thing Saunders will likely do is buy back a lot of stock now that the share price is lower. After that, Cramer said there is a long list of beaten down biotech names that Saunders can pick up for a song.
At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.
